GlassScriptPhysician profile
Jesus E Garza
NPI 1821485509
$3,250.21
in general payments reported to CMS, 2019-2025
12 companies · $1,171 in 2025
The $1,171 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $778 · 2022: $133 · 2023: $17.34 · 2024: $1,150 · 2025: $1,171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,338.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,104.72 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $1,060.85 | 2021-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $822.78 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Amarin Pharma, INC. | $52.00 | 2021 | |
| Boston Scientific Corporation | $45.08 | 2021 | |
| Exact Sciences Corporation | $37.95 | 2025 | Cologuard Collection Kit |
| Genentech USA, INC. | $28.60 | 2021 | |
| Abbvie INC. | $28.43 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.52 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.49 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.61 | 2024 | Jardiance |
| Cumberland Pharmaceuticals, INC. | $12.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesus Garza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.